[S-04] Update on Diagnostic Biomarkers for the early diagnosis of Alzheimer's Disease

[S-04-1] Updates on PET imaging of tau pathologies

Makoto Higuchi (National Institutes for Quantum and Radiological Science and Technology, Japan)

In recent advance of Alzheimer research field, development of tau imaging　and novel plasma biomarkers provide new prospect of clinical research and drug development. In this symposium, four presentators will be presenting and discussing on diagnostic biomarkers and their impacts on the diagnosis of Alzheimer's disease.

1987-1993 Tohoku University School of Medicine
1993-1997 Tohoku University Graduate School of Medicine
1997-1999 Staff Physician, Department of Geriatric Medicine, Tohoku University School of Medicine
1999-2003 Postdoctoral Researcher, Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine
2003-2005 Staff Scientist, Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute
2005-2016 Team Leader, National Institute of Radiological Sciences
2016-2018 Team Leader, National Institutes for Quantum and Radiological Science and Technology
2018- Deputy Department Director, National Institutes for Quantum and Radiological Science and Technology

Specialty and research interest: clinical and non-clinical molecular imaging of neuropsychiatric disorders